Skin Ailments

Much research has gone into exploring the use of human FGF-1 as a potential wound healing agent. Preclinical work with diabetic foot ulcers, venous ulcers, burns and other dermal wounds indicates that FGF-1 can greatly accelerate the rate of wound healing, which can dramatically improve the outcomes in patients, especially in such chronic wounds as diabetic foot ulcers where these wounds can become infected leading to the possibility of a lower limb amputation. Zhittya Genesis Medicine is advancing FGF-1 as a potential treatment for a number of wound healing indications, where it has been shown that increasing blood perfusion in the wound bed, through angiogenesis, can significantly enhance the closure rate of different types of wounds.

See White Papers that have been prepared for the following wound healing indications: